X0202 SCHEDULE 13G/A 0001493152-24-042119 0001595855 XXXXXXXX LIVE 6 Common Stock, par value $0.001 per share 05/01/2026 0001417663 SANUWAVE Health, Inc. 80303D305 3360 Martin Farm Rd Suite 100 Suwanee GA 30024 Rule 13d-1(c) Opaleye Management Inc. MA 0.00 858569.00 0.00 858569.00 858569.00 N 9.99 IA CO Opaleye, L.P. MA 0.00 853569.00 0.00 853569.00 853569.00 N 9.93 PN Based on 8,594,209 Common Shares outstanding as of 03/24/2026 as reported by SANUWAVE Health, Inc. on 03/26/2026, in its Form 10-K. James Silverman X1 0.00 858569.00 0.00 858569.00 858569.00 N 9.99 IN SANUWAVE Health, Inc. 3360 Martin Farm Rd, Suite 100, Suwanee, GA, 30024 This statement is filed by (i) Opaleye Management Inc. (the "Adviser"), (ii) Opaleye, L.P. (the "Fund") and (iii) James Silverman (collectively, the "Reporting Persons"). The Fund directly holds 853,569 shares of common stock, par value $0.001 per share (the "Common Stock"), of SANUWAVE Health, Inc. (the "Issuer"). The Adviser, as investment adviser to the Fund and certain separately managed accounts, and Mr. Silverman, as the controlling person of the Adviser, may be deemed to beneficially own an aggregate of 858,569 shares of Common Stock. The filing of this statement shall not be construed as an admission that any Reporting Person is the beneficial owner of any securities covered by this statement for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or otherwise. One Boston Place, 26th Floor, Boston, MA 02108 Opaleye Management Inc. - Massachusetts Opaleye, L.P. - Massachusetts James Silverman - United States Y 858,569.00 9.99 % 0 858,569.00 0 858,569.00 Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 Joint Filing Agreement by and among the reporting persons Opaleye Management Inc. /s/ James Silverman 05/04/2026 Opaleye, L.P. /s/ James Silverman 05/04/2026 James Silverman /s/ James Silverman 05/04/2026